Published in Pediatr Infect Dis J on December 01, 2010
Economic value of dengue vaccine in Thailand. Am J Trop Med Hyg (2011) 1.07
Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother (2013) 0.93
Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis (2012) 0.83
Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hum Vaccin Immunother (2017) 0.82
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India. BMC Infect Dis (2014) 0.81
Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine. Infect Dis Ther (2013) 0.80
Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children. Hum Vaccin Immunother (2013) 0.80
Japanese Encephalitis Vaccines. J Bioterror Biodef (2011) 0.79
Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka. PLoS One (2015) 0.77
Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review. Hum Vaccin Immunother (2014) 0.76
A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea. Hum Vaccin Immunother (2014) 0.75
Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis. Hum Vaccin Immunother (2015) 0.75
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet (2012) 12.41
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med (2014) 6.58
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med (2015) 4.79
The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg (2010) 4.09
Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med (2013) 3.09
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. Vaccine (2008) 1.89
Myocardial depression in dengue hemorrhagic fever: prevalence and clinical description. Pediatr Crit Care Med (2007) 1.62
Dengue in Thailand and Cambodia: an assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis (2011) 1.61
Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children. J Antimicrob Chemother (2009) 1.47
Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine. Vaccine (2004) 1.43
Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis (2012) 1.29
Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost (2007) 1.28
Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children. Pediatr Infect Dis J (2005) 1.26
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children. AIDS Res Ther (2011) 1.22
Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children. J Infect Dis (2006) 1.22
Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children. PLoS Negl Trop Dis (2013) 1.18
Dengue infection in children in Ratchaburi, Thailand: a cohort study. I. Epidemiology of symptomatic acute dengue infection in children, 2006-2009. PLoS Negl Trop Dis (2012) 1.15
Mucocutaneous findings in pediatric AIDS related to degree of immunosuppression. Pediatr Dermatol (2003) 1.13
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis (2012) 1.12
Dengue infection: a global concern. J Med Assoc Thai (2002) 1.11
Dengue infection: a growing global health threat. Biosci Trends (2007) 1.10
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine (2012) 1.09
Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America. Pediatr Infect Dis J (2013) 1.07
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore. Hum Vaccin Immunother (2012) 1.06
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine. PLoS One (2010) 1.05
Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine (2010) 1.04
A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus. AIDS Res Hum Retroviruses (2010) 1.04
Scientific consultation on immunological correlates of protection induced by dengue vaccines report from a meeting held at the World Health Organization 17-18 November 2005. Vaccine (2007) 1.03
A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine. AIDS Res Hum Retroviruses (2008) 1.01
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine. PLoS One (2010) 1.01
Dengue infection in children in Ratchaburi, Thailand: a cohort study. II. Clinical manifestations. PLoS Negl Trop Dis (2012) 1.01
Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age. J Allergy Clin Immunol (2010) 1.00
Hemodynamic profiles of patients with dengue hemorrhagic fever during toxic stage: an echocardiographic study. Intensive Care Med (2003) 1.00
Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs. Clin Infect Dis (2005) 1.00
Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. Vaccine (2010) 1.00
Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. Vaccine (2006) 1.00
Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai (2002) 0.99
Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J (2009) 0.98
Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants. Pediatr Infect Dis J (2012) 0.97
Seroprevalence of anti-RSV IgG in Thai children aged 6 months to 5 years. Asian Pac J Allergy Immunol (2003) 0.96
Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Hum Vaccin Immunother (2012) 0.96
Short report: immune response and occurrence of dengue infection in thai children three to eight years after vaccination with live attenuated tetravalent dengue vaccine. Am J Trop Med Hyg (2006) 0.93
Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA. Vaccine (2013) 0.91
Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand. Virol J (2014) 0.91
Age-specific prevalence of dengue antibodies in Bangkok infants and children. Pediatr Infect Dis J (2008) 0.91
Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials. Vaccine (2010) 0.91
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J (2014) 0.91
Serum and urine sodium levels in dengue patients. Southeast Asian J Trop Med Public Health (2005) 0.89
Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study. Vaccine (2013) 0.89
A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pediatr Infect Dis J (2009) 0.88
Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals. AIDS Res Ther (2006) 0.88
Decay and persistence of maternal dengue antibodies among infants in Bangkok. Am J Trop Med Hyg (2011) 0.87
The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children. Vaccine (2011) 0.87
A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis (2009) 0.87
Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. PLoS One (2008) 0.86
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico. Hum Vaccin Immunother (2014) 0.86
Hospital-based epidemiologic survey of malignancies in children infected with human immunodeficiency virus in Thailand. Pediatr Infect Dis J (2005) 0.85
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS Res Ther (2008) 0.85
The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months. J Med Assoc Thai (2005) 0.84
Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J (2014) 0.84
Efficacy of the human rotavirus vaccine RIX4414 in malnourished children. J Infect Dis (2007) 0.84
Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease. J Neurol (2006) 0.84
Antibody response to hepatitis B immunization in infants born to HIV-infected mothers. J Med Assoc Thai (2002) 0.83
Endocarditis and pericarditis caused by Salmonella paratyphi A: two case reports and review of the literature. Southeast Asian J Trop Med Public Health (2002) 0.83
Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore. Hum Vaccin Immunother (2013) 0.82
Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children. Trans R Soc Trop Med Hyg (2008) 0.82
A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia. J Infect Dis (2013) 0.81
Immunization for persons infected with human immunodeficiency virus. Curr HIV Res (2004) 0.81
Recurrent purpura fulminans associated with drug-resistant Streptococcus pneumoniae infection in an asplenic girl. Pediatr Infect Dis J (2002) 0.81
Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression. Vaccine (2011) 0.81
The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2011) 0.81
Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' reply. Lancet (2013) 0.81
Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam. J Trop Pediatr (2007) 0.81
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India. BMC Infect Dis (2014) 0.81
Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative. Southeast Asian J Trop Med Public Health (2012) 0.81
Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants. Int J Infect Dis (2011) 0.81
Maternally transferred neutralising dengue antibodies in Thai infants: a pilot study. Ann Trop Paediatr (2003) 0.80
Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children. Hum Vaccin Immunother (2013) 0.80
Post-operative meningitis caused by drug-resistant Streptococcus pneumoniae: two case reports. Scand J Infect Dis (2004) 0.80